局部晚期肝门部胆管癌联合血管切除的疗效与安全性
该研究纳入2001-2018年1055例肝门部胆管癌患者,其中787例(75%)接受切除,分为无血管切除(n=484)、门静脉切除(PVR,n=157)和肝动脉切除(HAR,n=146)。联合血管切除(VR)组并发症发生率为50%(无VR组48%,P=0.715),死亡率为3.6%(无VR组1.2%,P=0.040);VR组中位总生存(OS)为30个月,短于无VR组的61个月(P<0.0001),但长于未切除组的10个月(P<0.0001);PVR与HAR组OS无显著差异(中位29个月 vs 34个月,P=0.517)。结论认为,在肝门部入肝血管可重建的情况下,VR可使局部晚期患者获得手术机会并带来生存获益。
要点
- 联合血管切除适用于肝门部入肝血管可重建的局部晚期肝门部胆管癌。
- VR组并发症发生率与无VR组相当,但术后死亡率略高(3.6% vs 1.2%)。
- VR组中位OS 30个月,优于未切除组的10个月,但短于无VR组的61个月。
核心结论
- 联合血管切除可使局部晚期肝门部胆管癌患者获得手术切除机会,在入肝血管可重建时推荐实施,并提供可接受的手术结局和显著生存获益。
研究设计与样本
- 回顾性研究纳入2001-2018年诊断为肝门部胆管癌的连续患者1055例,其中787例(75%)接受切除,按是否联合血管切除分组,VR组再按血管切除类型(PVR或HAR)细分,比较术后结局和OS。
主要发现
- 切除患者中无VR组484例,PVR组157例,HAR组146例。
- 术后并发症发生率:无VR组48% vs VR组50%(P=0.715);术后死亡率:无VR组1.2% vs VR组3.6%(P=0.040)。
- VR组中位OS为30个月,短于无VR组的61个月(P<0.0001),但长于未切除组的10个月(P<0.0001)。
- PVR组与HAR组中位OS分别为29个月和34个月,差异无统计学意义(P=0.517)。
临床怎么用
- 对于局部晚期肝门部胆管癌,若肝门部入肝血管可重建,可考虑联合血管切除以争取根治性切除。
- 联合血管切除术后死亡风险略高于无血管切除,需权衡手术风险与生存获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy and safety of combined vascular resection (VR) in advanced perihilar cholangiocarcinoma (PHC). SUMMARY OF BACKGROUND DATA: Hepatectomy combined with portal vein resection (PVR) and/or hepatic artery resection (HAR) is technically demanding but an option only for tumor eradication against PHC involving the hilar hepatic inflow vessels; however, its efficacy and safety have not been well evaluated. METHODS: Patients diagnosed with PHC during 2001-2018 were included. Patients who underwent resection were divided according to combined VR. Patients undergoing VR were subdivided according to type of VR. Postoperative outcomes and OS were compared between patient groups. RESULTS: Among the 1055 consecutive patients, 787 (75%) underwent resection (without VR: n = 484, PVR: n = 157, HAR: n = 146). The incidences of postoperative complications and mortality were 49% (without VR vs with VR, 48% vs 50%; P= 0.715) and 2.1% (without VR vs with VR, 1.2% vs 3.6%; P= 0.040), respectively. The OS of patients who underwent resection with VR (median, 30 months) was shorter than that of those who underwent resection without VR (median, 61 months; P < 0.0001); however, it was longer than that of those who did not undergo resection (median, 10 months; P < 0.0001). OS was not significantly different between those who underwent PVR and those who underwent HAR (median, 29 months vs 34 months; P = 0.517). CONCLUSION: VR salvages a large number of patients from having locally advanced PHC that is otherwise unresectable and is recommended if the hilar hepatic inflow vessels are reconstructable, providing acceptable surgical outcomes and substantial survival benefits.
引用
- Mizuno T, Ebata T, Yokoyama Y, et al. Combined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma. Ann Surg. 2022. PMID: 32976284. doi:10.1097/SLA.0000000000004322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。